Zacks Investment Research on MSN
All you need to know about Immuneering (IMRX) rating upgrade to buy
Immuneering Corporation (IMRX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...
Investors might want to bet on Stock Yards Bancorp (SYBT), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is ...
CompoSecure, Inc. (CMPO) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback